Using QCM-D in the development of broad-spectrum antiviral drugs
13 Apr, 2022 | Newsletters
![Using QCM-D in the development of broad-spectrum antiviral drugs](https://cdn-gddfb.nitrocdn.com/XMOCPBDkJQcfbMeyrNhpgTZaRuIaedyd/assets/images/optimized/rev-a3b8fe2/www.atascientific.com.au/wp-content/uploads/2022/06/97bce28c-ee99-006e-87f1-d2ac7d014f14.jpg)
Considering the ongoing Covid-19 pandemic, and the tremendous negative impact it has had, and still has, antiviral drug development is a highly relevant topic. Here we present two studies where QSense QCM-D technology was used to explore viral membrane disruption and an antiviral strategy towards pandemic preparedness. Study A: Use QCM-D to analyse membrane−peptide interactions and membrane disruption Study B: Using QCM-D to analyse rupture of lipid vesicles by a Broad-Spectrum Antiviral Peptide and the influence of vesicle size |
READ MORE HERE |
Request a personal demo Request a quote now Email us for more info |